Critical Pharmaceuticals has completed second clinical trial on CP024 intranasal growth hormone. CP024 growth hormone nasal spray was safe and well tolerated in the study that administered six dose levels of CP024 in healthy subjects. ...
Rigid plastic packaging and devices manufacturer Rexam Healthcare has announced the expansion of its La Verpillière site near Lyon in France to create a building including about 2400m² of clean room. The company will produce ...
Canada’s Generex Biotechnology, through its Indian licensee Shreya Life Sciences, has submitted a dossier of recently concluded Phase III trial results of its oral insulin ‘Generex Oral-lyn’ to the Indian government for ...
Tags: Generex Biotechnology, Shreya Life Sciences, oral insulin
TVM Life Science Ventures VII has made the first investment in Montreal-based Kaneq Bioscience, a spin out company of Kaneq Pharma. Kaneq Bioscience was created for developing a protein tyrosine phosphatase1B (PTP-1B) inhibitor, designed ...
Tags: TVM Life Science, Pharma, Kaneq Pharma
The European Commission has issued clearance to market Novo Nordisk's diabetes therapies, Tresiba and Ryzodeg, across 27 European Union (EU) states. Novo Nordisk anticipates launching Tresiba, brand name of insulin degludec, in the UK and ...
Tags: Ryzodeg diabetes drugs, injection doses, diabetes therapies
A Philips information management system, which is used in making administrative chores in hospital more efficient, contains vulnerabilities that can be exploited to gain full control of the product, a security vendor said on Thursday. ...
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Hygieia's claims related to Diabetes Insulin Guidance system (DIGS) technology. The patent covers a system which automatically optimizes a patient's ...
Tags: USPTO, NOA, Hygieia, DIGS technology
Eli Lilly and Company has reassumed the worldwide development and commercialization rights for novel basal insulin analog giving a scope to diabetes alliance signed with Boehringer concerning LY2605541. Lilly also considers initiating ...
Tags: Eli Lilly, commercialization rights, Boehringer, company news
The Japanese Ministry of Health, Labour and Welfare has cleared Novo Nordisk's diabetes therapy, Ryzodeg. Ryzodeg, which has been approved to be administered once or twice daily, is the global brand name for insulin degludec/insulin ...
Tags: Novo Nordisk, diabetes therapy, Japan, Health
Pacemakers from several manufacturers can be commanded to deliver a deadly, 830-volt shock from someone on a laptop up to 50 feet away, the result of poor software programming by medical device companies. The new research comes from ...
Tags: Pacemakers, shock, laptop, software programming, medical device companies
The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, has asked diabetic patients using Hypurin Porcine Isophane insulin cartridges to check their medication following a packaging error. The error came to light when ...
Tags: diabetic patients, Medicines products, Healthcare products, medication
The technology company The Linde Group has signed an agreement to acquire the homecare company Calea France SAS (Sèvres, France). Calea generated revenue in the 2011 financial year of EUR 28 million with around 200 employees. The ...
Tags: Linde, Acquires, oxygen therapy, sleep therapy, ventilation services
Insulet has gained the US Food and Drug Administration's (FDA) 510(k) approval for its new version of tubeless insulin pump. The new easy-to-use OmniPod insulin management system features the same 200-unit insulin reservoir capacity, ...
Tags: FDA, Insulet, tubeless insulin pump, clinical technology
Clinical stage biotechnology company Aphios has obtained notification of allowance(NOA)from the US Patent and Trademark Office(USPTO)for its patent application for oral delivery of insulin. The patent entitled'Polymer ...
Tags: Aphios, USPTO, oral delivery of insulin, NOA
Research and advisory firm, Gartner, has released its list of technology predictions and trends for the years 2013 and beyond. According to Gartner, its top predictions focus on economic risks, opportunities and innovations that will ...
Tags: CIO, Gartner, IT, predictions, research, technology